Scientists hunt for genetic clues to Menière's disease
NCT ID NCT07518069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to uncover genetic and biological differences between people with Menière's disease, those with vestibular migraine, and healthy individuals. Researchers will analyze blood samples from 250 participants to look for specific gene variations and biohumoral factors. The goal is to better understand what causes these conditions and how they differ.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify genetic markers or biological factors that distinguish Menière's disease from vestibular migraine, potentially guiding future diagnostic or treatment approaches.
- What could go wrong
- This is an observational study, not a treatment trial. It is exploratory and may not lead to immediate clinical changes. Results may not apply to non-Caucasian populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 250 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients were included if they fulfilled criteria for definite unilateral MD according to the Barany Society; in subjects enrolled before 2015 a retrospective analysis of data confirmed Barany criteria
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with definite Menière's Disease according to the criteria of the Barany Society Exclusion Criteria: * surgically treated before the examination or if they had undergone intratympanic therapy with steroids or gentamicin
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Meniere's disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
IRCCS San Raffaele
RECRUITINGMilan, Italy, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily pill quiet the spinning of vertigo?
- 6,000 patients, one big question: what really causes dizziness?
- Wearable eye-tracker aims to catch dizziness in the act
- Can a new migraine drug stop the dizzy spells?
- Could a new drug quiet the ringing and dizziness of Meniere's disease?
- Ringing relief? migraine drugs tested for tinnitus in new study